Tech Company Financing Transactions
Phlow Funding Round
On 2/17/2021, Phlow raised $20 million in Series A funding from private investors.
Transaction Overview
Company Name
Announced On
2/17/2021
Transaction Type
Venture Equity
Amount
$20,000,000
Round
Series A
Investors
Proceeds Purpose
The company intends to use the funds to build its commercial business team, establish its commercial business unit's data and analytics platforms, advance the commercial research and development of APIs and finished pharmaceutical products, and fund innovative initiatives to improve the delivery of essential medicines.
Company Information
Company Status
Private & Independent
Industry
Healthcare IT
Mailing Address
737 N 5th St.
Richmond, VA 23298
USA
Richmond, VA 23298
USA
Phone
Website
Email Address
Overview
Phlow was formed to manufacture affordable, high quality, essential medicines for the United States. To help our nation secure its own strategic medicine reserve, Phlow will use novel and innovative methods in the medicine manufacturing industry to support our customers, including the U.S. government and to reduce the U.S.'s dependency on foreign supply chains.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Eric Edwards
Chief Financial Officer
Robert Mooney
Chief Medical Officer
David Levin
Chief Operating Officer
Glenn Gerecke
Vice President
Andrew Stiles
VP - Bus. Development
Daniel Hackman
Browse more venture capital transactions:
Prev: 2/17/2021: Citadel ID venture capital transaction
Next: 2/17/2021: Centessa Pharmaceuticals venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on every notable VC transaction. VC investment data records reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs